GSK, Vir Biotech to expand COVID-19 research partnership for other diseases - Reuters

Reuters | Feb. 17, 2021, 7:13 a.m. | Original
GSK, Vir Biotech to expand COVID-19 research partnership for other diseases Reuters
UPDATE 1-Origin Materials to go public via $1.8 bln SPAC merger - Reuters Pay gap for U.S. female executives narrows but persists - Reuters